CCO Expert Recap

Gastrointestinal ER

Source: 2007 American Society of Clinical Oncology Annual Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Gastrointestinal Cancer: CCO Independent Conference Coverage of the 2007 Annual Meeting of the American Society of Clinical Oncology

Faculty:
John L. Marshall, MD

CME CREDIT INFORMATION

Release Date: 08/14/07

Expiration Date: 08/13/08

Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Registered Nurses: 0.8 Nursing CE credit

Status: Please log in to view status

John L. Marshall, MD, summarizes recent data about the use of chemotherapy and targeted agents for treatment of colon and rectal cancers, gastric and esophageal cancers, hepatocellular carcinoma, and pancreatic cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the results of recent clinical trials using US Food and Drug Administration–approved or investigational agents for the treatment of colorectal cancer
Relate results from investigation of novel treatment options in hepatocellular carcinoma
Summarize data regarding novel chemotherapeutic approaches and combined modality options for treatment of esophageal and gastric cancers
Articulate status of use of targeted agents with chemotherapy for pancreatic cancer

Slideset

GI Slides

CCO’s slides summarizing important new data presented at medical conferences, printed in journal articles, or those used by speakers in live programs (satellites, dinner meetings, or Webcasts) are made available to members free of charge to download for use in their own talks.

Format: Microsoft PowerPoint (.ppt) | File size: 1,409 KB